New pill tested to fight fatal lung scarring disease

NCT ID NCT05975983

Recruiting now Disease control Sponsor: InSilico Medicine Hong Kong Limited Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral drug called INS018_055 in 40 adults with Idiopathic Pulmonary Fibrosis (IPF), a serious lung-scarring disease. The main goal is to check the drug's safety and how the body processes it over 12 weeks. Researchers will also look for early signs that it might help slow the disease by measuring lung function and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bogan Sleep Consultants, LLC
RECRUITING

Columbia, South Carolina, 29201-2953, United States
Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando
RECRUITING

Orlando, Florida, 32803-5727, United States
Florida Lung Asthma and Sleep Specialist
RECRUITING

Celebration, Florida, 34747-1818, United States
HonorHealth Research Institute
RECRUITING

Scottsdale, Arizona, 85258, United States
Keck School of Medicine of USC
RECRUITING

Los Angeles, California, 90033, United States
Metroplex Pulmonary and Sleep Center
RECRUITING

McKinney, Texas, 75069-1898, United States
Research Centers of America
RECRUITING

McKinney, Texas, 75071, United States
Southeastern Research Center
RECRUITING

Winston-Salem, North Carolina, 27103-4007, United States
Temple University Hospital-Temple Lung Center
RECRUITING

Philadelphia, Pennsylvania, 19140, United States
University of Alabama at Birmingham
RECRUITING

Birmingham, Alabama, 35294, United States
University of Oklahoma Health Sciences Center (OUHSC)
RECRUITING

Oklahoma City, Oklahoma, 73104-5417, United States
University of Texas Southwestern Medical Center
RECRUITING

Dallas, Texas, 75235-6243, United States

Conditions

Explore the condition pages connected to this study.

IDIOPATHIC PULMONARY FIBROSIS (IPF)